← All stocks

Monopar Therapeutics

MNPR Net selling

CIK 0001645469 #2760 in the set updated 18 Sep 2026

Bought (12 mo)

$104.93K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$36.15M

$806.76K on a plan · $111.26 straight out of an exercise

Sold at will

$35.34M

3 of 13 sales

Net

−$36.05M

−$35.24M against sales at will

By person

12 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Tactic Pharma LLC entity

10% owner

—

$35.00M (1)

−$35.00M

272,026

4.05%

$30.97M

−68.2%

Tsuchimoto Kim R

Director

—

$455.57K (6) scheduled

−$455.57K

7,396

0.1102%

$841.96K

−35.6%

Anderson Raymond

Director

—

$351.19K (3) scheduled

−$351.19K

23,751

0.3538%

$2.70M

−11.7%

KLAUSNER ARTHUR J

Director

—

$343.89K (2)

−$343.89K

8,762

0.1305%

$997.47K

+41.9%

Vu Quan Anh

Chief Financial Officer

$104.93K (1)

—

+$104.93K

2,221

0.0331%

$252.84K

—

RIOUX PATRICE

Acting Chief Medical Officer

—

$111.26 (1) scheduled

−$111.26

5,065

0.0755%

$576.60K

+37.4%

Hendricks Diane

10% owner

—

567,580

8.46%

$64.61M

−7.1%

Robinson Chandler

Chief Executive Officer

—

162,082

2.41%

$18.45M

+204.8%

Cittadine Andrew

Chief Operating Officer

—

55,614

0.8286%

$6.33M

+44.0%

STARR CHRISTOPHER M

Director

—

5,173

0.0771%

$588.89K

0.0%

Radhakrishnan Karthik

Chief Financial Officer

—

1,550

0.0231%

$176.45K

—

TacticGem LLC entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

RIOUX PATRICE

26 Aug 2026

Acting Chief Medical Officer

Sold after exercise

$111.26

Show all 14 transactions →

What was left out

Form 4 filings counted 29

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 9

Sales straight out of an exercise 1

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 127,725

History held since 27 Sep 2018